MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

MDT

100.71

0%↓

A

135.72

-0.01%↓

VEEV

217.61

-2.73%↓

HQY

82.76

-2.65%↓

NEOG

10.24

+2.4%↑

Search

Kala Pharmaceuticals Inc

Uždarymo kaina

0.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

0.49

Max

0.58

Pagrindiniai rodikliai

By Trading Economics

Dividendai

By Dow Jones

Kitas uždarbis

2026-03-30

Kala Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-01-27 23:07; UTC

Uždarbis

Texas Instruments Says Data Centers, Industrial Recovery Driving Growth into 1Q -- Update

2026-01-27 21:27; UTC

Uždarbis

Texas Instruments 4Q Sales Rise, Profit Falls

2026-01-27 23:55; UTC

Rinkos pokalbiai

Yen Weakens Slightly on Possible Technical Correction -- Market Talk

2026-01-27 23:47; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2026-01-27 23:47; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Caution Over Earnings -- Market Talk

2026-01-27 23:39; UTC

Rinkos pokalbiai

Gold Falls on Likely Technical Correction, Possible Profit-Taking -- Market Talk

2026-01-27 23:20; UTC

Uždarbis

SK Innovation: Asset-Impairment Losses Weighed on Earnings

2026-01-27 23:20; UTC

Uždarbis

SK Innovation: Industry Downturn, Narrower Profit Margins Weighed on Earnings

2026-01-27 23:19; UTC

Uždarbis

SK Innovation Posts Net Loss for Second Consecutive Year

2026-01-27 23:19; UTC

Uždarbis

SK Innovation 2025 Loss KRW5.406T Vs. Loss KRW2.372T >096770.SE

2026-01-27 23:18; UTC

Uždarbis

SK Innovation 2025 Oper Pft KRW448.07B Vs. Pft KRW356.07B >096770.SE

2026-01-27 23:18; UTC

Uždarbis

SK Innovation 2025 Rev KRW80.296T Vs. KRW74.243T >096770.SE

2026-01-27 23:11; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2026-01-27 23:11; UTC

Rinkos pokalbiai

Alkane Resources Bull Positive on Outlook in Red-Hot Gold Market -- Market Talk

2026-01-27 23:07; UTC

Rinkos pokalbiai
Įsigijimai, susijungimai, perėmimai

Freightways's Australian M&A Adds Ballast to Bull's View -- Market Talk

2026-01-27 22:17; UTC

Rinkos pokalbiai

U.S. Dollar Slips Following Trump Comments -- Market Talk

2026-01-27 22:06; UTC

Uždarbis

Boeing's Stepped-Up Plane Deliveries Lift Sales -- Update

2026-01-27 21:51; UTC

Uždarbis

Texas Instruments Stock Jumps on Strong Outlook -- Barrons.com

2026-01-27 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2026-01-27 21:43; UTC

Uždarbis

RTX Stock Jumps After Earnings. It Has 'Great Momentum,' Says CEO. -- Barrons.com

2026-01-27 21:41; UTC

Uždarbis

GM Lost Billions on EVs, Still Beat Wall Street's Expectations -- 5th Update

2026-01-27 21:38; UTC

Uždarbis

These Stocks Are Today's Movers: UnitedHealth, Humana, Micron, Corning, CoreWeave, UPS, GM, and More -- Barrons.com

2026-01-27 21:32; UTC

Uždarbis

Ampol: Modest Profit From F&I International in 2025

2026-01-27 21:32; UTC

Uždarbis

Ampol: F&I Australia Ebit Up by High Single Digit Percent in 2025

2026-01-27 21:31; UTC

Uždarbis

Ampol: New Zealand Ebit in 2025 In Line With Prior Year

2026-01-27 21:31; UTC

Uždarbis

Ampol: Australia Convenience Retail Ebit Up Mid-Single Digit Percent in 2025

2026-01-27 21:30; UTC

Uždarbis

Ampol 4Q Lytton Refinery Production 1.56 Billion Liters

2026-01-27 21:29; UTC

Uždarbis

Ampol FY Unaudited Replacement-Cost Ebitda A$1.44 Billion

2026-01-27 21:29; UTC

Uždarbis

Ampol FY Unaudited Replacement-Cost Operating Profit A$945 Million

2026-01-27 21:28; UTC

Uždarbis

Ampol 4Q Lytton Refiner Margin US$15.14/Bbl

Akcijų palyginimas

Kainos pokytis

Kala Pharmaceuticals Inc Prognozė

Bendras įvertinimas

By TipRanks

0 ratings

0

Pirkti

0

Laikyti

0

Parduoti

Finansinės naujienos

$

Apie bendrovę Kala Pharmaceuticals Inc

Kala Pharmaceuticals Inc
help-icon Live chat